Pfizer Seeking FDA Approval to Vaccinate Children Ages 5 and Up
September 20, 2021
Neal D. Goldstein, PhD, an assistant research professor in the Dornsife School of Public Health, was quoted in a Sept. 2 Courthouse News article about recent data on a lower dose of the Pfizer-BioNTech Covid-19 vaccine in kids ages 5 to 11.
Link to story